OBJECTIVE: Our aim was to compare the clinical characteristics, prophylaxis, treatment, and outcomes of venous thromboembolism in patients with and without previously diagnosed chronic obstructive pulmonary disease. METHODS: We analyzed the population-based Worcester Venous Thromboembolism Study of 2488 consecutive patients with validated venous thromboembolism to compare clinical characteristics, prophylaxis, treatment, and outcomes in patients with and without chronic obstructive pulmonary disease. RESULTS: Of 2488 patients with venous thromboembolism, 484 (19.5%) had a history of clinical chronic obstructive pulmonary disease and 2004 (80.5%) did not. Patients with chronic obstructive pulmonary disease were older (mean age 68 vs 63 years) and had a higher frequency of heart failure (35.5% vs 12.9%) and immobility (53.5% vs 43.3%) than patients without chronic obstructive pulmonary disease (all P<.0001). Patients with chronic obstructive pulmonary disease were more likely to die in hospital (6.8% vs 4%, P=.01) and within 30 days of venous thromboembolism diagnosis (12.6% vs 6.5%, P<.0001). Patients with chronic obstructive pulmonary disease demonstrated increased mortality despite a higher frequency of venous thromboembolism prophylaxis. Immobility doubled the risk of in-hospital death (adjusted odds ratio, 2.21; 95% confidence interval, 1.35-3.62) and death within 30 days of venous thromboembolism diagnosis (adjusted odds ratio, 2.04; 95% confidence interval, 1.43-2.91). CONCLUSION: Patients with chronic obstructive pulmonary disease have an increased risk of dying during hospitalization and within 30 days of venous thromboembolism diagnosis. Immobility in patients with chronic obstructive pulmonary disease is an ominous risk factor for adverse outcomes.
OBJECTIVE: Our aim was to compare the clinical characteristics, prophylaxis, treatment, and outcomes of venous thromboembolism in patients with and without previously diagnosed chronic obstructive pulmonary disease. METHODS: We analyzed the population-based Worcester Venous Thromboembolism Study of 2488 consecutive patients with validated venous thromboembolism to compare clinical characteristics, prophylaxis, treatment, and outcomes in patients with and without chronic obstructive pulmonary disease. RESULTS: Of 2488 patients with venous thromboembolism, 484 (19.5%) had a history of clinical chronic obstructive pulmonary disease and 2004 (80.5%) did not. Patients with chronic obstructive pulmonary disease were older (mean age 68 vs 63 years) and had a higher frequency of heart failure (35.5% vs 12.9%) and immobility (53.5% vs 43.3%) than patients without chronic obstructive pulmonary disease (all P<.0001). Patients with chronic obstructive pulmonary disease were more likely to die in hospital (6.8% vs 4%, P=.01) and within 30 days of venous thromboembolism diagnosis (12.6% vs 6.5%, P<.0001). Patients with chronic obstructive pulmonary disease demonstrated increased mortality despite a higher frequency of venous thromboembolism prophylaxis. Immobility doubled the risk of in-hospital death (adjusted odds ratio, 2.21; 95% confidence interval, 1.35-3.62) and death within 30 days of venous thromboembolism diagnosis (adjusted odds ratio, 2.04; 95% confidence interval, 1.43-2.91). CONCLUSION:Patients with chronic obstructive pulmonary disease have an increased risk of dying during hospitalization and within 30 days of venous thromboembolism diagnosis. Immobility in patients with chronic obstructive pulmonary disease is an ominous risk factor for adverse outcomes.
Authors: Frederick A Spencer; Cathy Emery; Darleen Lessard; Frederick Anderson; Sri Emani; Jayashri Aragam; Richard C Becker; Robert J Goldberg Journal: J Gen Intern Med Date: 2006-07 Impact factor: 5.128
Authors: Manuel Monreal; Juan Francisco Sanchez Muñoz-Torrero; Virjanand S Naraine; David Jiménez; Silvia Soler; Ramón Rabuñal; Pedro Gallego Journal: Am J Med Date: 2006-10 Impact factor: 4.965
Authors: Gregory Piazza; Samuel Z Goldhaber; Darleen M Lessard; Robert J Goldberg; Catherine Emery; Frederick A Spencer Journal: Am J Med Date: 2011-03 Impact factor: 4.965
Authors: Victor Kim; Nishant Goel; Jinal Gangar; Huaqing Zhao; David E Ciccolella; Edwin K Silverman; James D Crapo; Gerard J Criner Journal: Chronic Obstr Pulm Dis Date: 2014
Authors: Behnood Bikdeli; Yun Wang; Karl E Minges; Nihar R Desai; Nancy Kim; Mayur M Desai; John A Spertus; Frederick A Masoudi; Brahmajee K Nallamothu; Samuel Z Goldhaber; Harlan M Krumholz Journal: J Am Coll Cardiol Date: 2016-03-08 Impact factor: 24.094
Authors: Marisa Ninivaggi; Marieke de Laat; Marcus M D Lancé; Cécile H Kicken; Leonie Pelkmans; Saartje Bloemen; Marlou L Dirks; Luc J C van Loon; José W P Govers-Riemslag; Theo Lindhout; Joke Konings; Bas de Laat Journal: PLoS One Date: 2015-10-30 Impact factor: 3.240
Authors: Henna Maria Ala-Seppälä; Mika Tapani Ukkonen; Antti Ilmari Lehtomäki; Emilia Susanna Pohja; Jaakko Juhani Nieminen; Jari Olavi Laurikka; Jahangir Ari Khan Journal: Lung Date: 2020-06-30 Impact factor: 2.584
Authors: Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-05-07
Authors: Huifang Liang; Raghava Danwada; Dianlin Guo; Jeffrey R Curtis; Ryan D Kilpatrick; Barbara Hendrickson; Syed S Islam Journal: RMD Open Date: 2019-09-23